These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 7528214)
21. Mutational patterns in the HIV genome and cross-resistance following nucleoside and nucleotide analogue drug exposure. Miller V; Larder BA Antivir Ther; 2001; 6 Suppl 3():25-44. PubMed ID: 11678471 [TBL] [Abstract][Full Text] [Related]
22. A nonnucleoside reverse transcriptase inhibitor active on human immunodeficiency virus type 1 isolates resistant to related inhibitors. Goldman ME; O'Brien JA; Ruffing TL; Schleif WA; Sardana VV; Byrnes VW; Condra JH; Hoffman JM; Emini EA Antimicrob Agents Chemother; 1993 May; 37(5):947-9. PubMed ID: 7685996 [TBL] [Abstract][Full Text] [Related]
23. The observed inhibitory potency of 3'-azido-3'-deoxythymidine 5'-triphosphate for HIV-1 reverse transcriptase depends on the length of the poly(rA) region of the template. Ma QF; Bathurst IC; Barr PJ; Kenyon GL Biochemistry; 1992 Feb; 31(5):1375-9. PubMed ID: 1371070 [TBL] [Abstract][Full Text] [Related]
26. Analysis of HIV-2 RT mutants provides evidence that resistance of HIV-1 RT and HIV-2 RT to nucleoside analogs involves a repositioning of the template-primer. Perach M; Rubinek T; Hughes SH; Hizi A J Mol Biol; 1997 May; 268(3):648-54. PubMed ID: 9171288 [TBL] [Abstract][Full Text] [Related]
27. Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance. Tantillo C; Ding J; Jacobo-Molina A; Nanni RG; Boyer PL; Hughes SH; Pauwels R; Andries K; Janssen PA; Arnold E J Mol Biol; 1994 Oct; 243(3):369-87. PubMed ID: 7525966 [TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological evaluation of certain alkenyldiarylmethanes as anti-HIV-1 agents which act as non-nucleoside reverse transcriptase inhibitors. Cushman M; Golebiewski WM; Graham L; Turpin JA; Rice WG; Fliakas-Boltz V; Buckheit RW J Med Chem; 1996 Aug; 39(16):3217-27. PubMed ID: 8759644 [TBL] [Abstract][Full Text] [Related]
29. Implication of the tRNA initiation step for human immunodeficiency virus type 1 reverse transcriptase in the mechanism of 3'-azido-3'-deoxythymidine (AZT) resistance. Vaccaro JA; Anderson KS Biochemistry; 1998 Oct; 37(40):14189-94. PubMed ID: 9760256 [TBL] [Abstract][Full Text] [Related]
30. Mechanisms of resistance to nucleoside analogue inhibitors of HIV-1 reverse transcriptase. Menéndez-Arias L Virus Res; 2008 Jun; 134(1-2):124-46. PubMed ID: 18272247 [TBL] [Abstract][Full Text] [Related]
31. DNA chain termination activity and inhibition of human immunodeficiency virus reverse transcriptase by carbocyclic 2',3'-didehydro-2',3'-dideoxyguanosine triphosphate. Orr DC; Figueiredo HT; Mo CL; Penn CR; Cameron JM J Biol Chem; 1992 Feb; 267(6):4177-82. PubMed ID: 1371285 [TBL] [Abstract][Full Text] [Related]
32. Phenylethylthiazolylthiourea (PETT) non-nucleoside inhibitors of HIV-1 and HIV-2 reverse transcriptases. Structural and biochemical analyses. Ren J; Diprose J; Warren J; Esnouf RM; Bird LE; Ikemizu S; Slater M; Milton J; Balzarini J; Stuart DI; Stammers DK J Biol Chem; 2000 Feb; 275(8):5633-9. PubMed ID: 10681546 [TBL] [Abstract][Full Text] [Related]
33. Amino acid residues in HIV-2 reverse transcriptase that restrict the development of nucleoside analogue resistance through the excision pathway. Álvarez M; Nevot M; Mendieta J; Martínez MA; Menéndez-Arias L J Biol Chem; 2018 Feb; 293(7):2247-2259. PubMed ID: 29275329 [TBL] [Abstract][Full Text] [Related]
34. Selective action of 4'-azidothymidine triphosphate on reverse transcriptase of human immunodeficiency virus type 1 and human DNA polymerases alpha and beta. Chen MS; Suttmann RT; Papp E; Cannon PD; McRoberts MJ; Bach C; Copeland WC; Wang TS Biochemistry; 1993 Jun; 32(23):6002-10. PubMed ID: 7685186 [TBL] [Abstract][Full Text] [Related]
35. Colorimetric assays for evaluation of the mode of action of human immunodeficiency virus type 1 non-nucleoside reverse transcriptase inhibitors. Shao X; Rytting AS; Ekstrand DH; Vrang L; Källander CF; Gronowitz JS Antivir Chem Chemother; 1998 Mar; 9(2):167-76. PubMed ID: 9875388 [TBL] [Abstract][Full Text] [Related]
36. Kinetic and mutational analysis of human immunodeficiency virus type 1 reverse transcriptase inhibition by inophyllums, a novel class of non-nucleoside inhibitors. Taylor PB; Culp JS; Debouck C; Johnson RK; Patil AD; Woolf DJ; Brooks I; Hertzberg RP J Biol Chem; 1994 Mar; 269(9):6325-31. PubMed ID: 7509800 [TBL] [Abstract][Full Text] [Related]
37. Affinity labeling and functional analysis of the primer binding domain of HIV-1 reverse transcriptase. Andreola ML; Tarrago-Litvak L; Levina AS; Kolocheva TI; el Dirani-Diab R; Jamkovoy VI; Khalimskaya NL; Barr PJ; Litvak S; Nevinsky GA Biochemistry; 1993 Apr; 32(14):3629-37. PubMed ID: 7682110 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of human immunodeficiency virus type 1 reverse transcriptase by 3'-blocked oligonucleotide primers. Austermann S; Kruhøffer M; Grosse F Biochem Pharmacol; 1992 Jun; 43(12):2581-9. PubMed ID: 1378738 [TBL] [Abstract][Full Text] [Related]
39. p66/p51 and p51/p51 recombinant forms of reverse transcriptase from human immunodeficiency virus type 1--interactions with primer tRNA(Lys3), initiation of cDNA synthesis, and effect of inhibitors. Dufour E; El Dirani-Diab R; Boulmé F; Fournier M; Nevinsky G; Tarrago-Litvak L; Litvak S; Andreola ML Eur J Biochem; 1998 Jan; 251(1-2):487-95. PubMed ID: 9492322 [TBL] [Abstract][Full Text] [Related]
40. Psychotrine and its O-methyl ether are selective inhibitors of human immunodeficiency virus-1 reverse transcriptase. Tan GT; Kinghorn AD; Hughes SH; Pezzuto JM J Biol Chem; 1991 Dec; 266(35):23529-36. PubMed ID: 1721050 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]